# A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants

> **NCT05288816** · PHASE1 · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ALXN1210

## Key facts

- **NCT ID:** NCT05288816
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-18
- **Primary completion:** 2017-07-05
- **Final completion:** 2017-07-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05288816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05288816, "A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05288816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*